The Korean government recently unveiled a new strategy to actively introduce artificial intelligence (AI) technology into bio research and development (R&D). The core of this strategy is to secure key technologies, such as AI foundation models for solving complex challenges in the bio sector, and to gradually build high-performance computing infrastructure dedicated to bio research.

The government plans to focus its support on four major areas: new drug development, precision medicine, green bio, and precision genome analysis. By integrating AI and robotics, the entire experimental process will be automated, and efforts will be made to establish public foundries and expand public-private cooperation ecosystems.

By 2035, the goal is to link 10 million public and private bio data cases to the National Bio Data Station, thereby enhancing data utilization and developing AI-driven privacy protection technologies. The government also aims to foster convergence talent in bio and AI, attract global scholars, and establish innovation hubs to strengthen the research ecosystem.

In particular, following the recent enactment of the Synthetic Biology Promotion Act, there will be initiatives to develop synthetic biology technologies, train professionals, expand international joint research, and build a national biofoundry. The government is committed to ensuring timely budget allocation, improving relevant laws and systems, and taking thorough follow-up measures.

* Article source : https://www.yna.co.kr/view/AKR20250430055700017